Viewing Study NCT07307235


Ignite Creation Date: 2026-03-26 @ 3:17 PM
Ignite Modification Date: 2026-03-29 @ 11:54 PM
Study NCT ID: NCT07307235
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-29
First Post: 2025-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
Sponsor: Shanghai Zhongshan Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 20250424044409703
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View